|
|
 |
INDUSTRY NEWS
Connexon Creative Launches Mesenchymal Cell News
Mesenchymal Cell News is a free, weekly e-newsletter that keeps the mesenchymal cell community informed by providing the latest news from all areas of the field, including its science, policy, and business.
BrainStorm Cell Therapeutics Enters into Agreement for Clinical-Grade Stem Cell Production for ALS
BrainStorm Cell Therapeutics Inc. announced recently that it has entered into an agreement with Protein Production Services Ltd. to start Good Manufacturing Practice production of its stem cell therapeutic product. [BrainStorm Cell Therapeutics, Petach Tikvah]
The Jordanian Stem Cell Company Acquires Stem Cell Technology from Stemedica International S.A.
Stemedica Cell Technologies, Inc. has announced recently that the Jordanian Stem Cell Company has signed a five year multi-million dollar agreement to purchase its stem cell and related technology. [Stemedica Cell Technologies, Inc., San Diego]
University of Missouri Licensing Revenue Hits $10 Million
The University of Missouri's technology transfer program topped $10 million in licensing income for the first time ever. [University of Missouri, St.Louis]
Biotech Startup Hopes Light-activated Nerve Cells will Make it a Northeast Ohio Star
LucCell Inc.'s light switches, which sprang from research at Case Western Reserve University, allow neurons silenced by a spinal cord injury or brain cells malfunctioning due to disease might someday resume working when triggered by flashes of laser light. [LucCell Inc., Cleveland]
Californian Budget Deficit Poses "Real Risk" to Biotech Investment
Biotech has played a large role in shaping California over the past 30 years but the new financial frugality has created a difficult relationship between the industry and the state.
United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
Stemedica Cell Technologies, Inc. has filed a patent application for the use of multiple stem cells and a transplantation methodology in the treatment of Diabetic Retinopathy. [Stemedica Cell Technologies, Inc., San Diego]
|
|
POLICY NEWS
Safety Call Over Stem Cell Trips
A clampdown on unproven and potentially unsafe stem cell research is being called for by an expert group.
How Will Science Fare?
This year, there is a new twist in the Japanese education ministry's budget requests: The newly elected Democratic Party now has responsibility for finalizing the budget, and no one knows how R&D will fare.
Ethics Scrutiny Needed for Chinese-European Projects
Biomedical research collaborations between Europe and China need greater ethical oversight to combat unregulated stem-cell therapies and prevent the exploitation of clinical-trial participants according to experts.
|
|
EVENTS
World Stem Cell Summit 2009
September 23-25, 2009
Baltimore, United States
TERMIS 2nd World Congress 2009
August 31 - September 3, 2009
Seoul, South Korea
49th American Society for Cell Biology Annual Meeting
December 5-9, 2009
San Diego, United States
Stem Cells and Regenerative Medicine World Congress
January 20-21, 2010
San Francisco, United States
Molecular Medicine Tri-Conference 2010
February 3-5, 2010
San Francisco, United States
ISSCR 8th Annual Meeting
June 16-19, 2010
San Francisco, United States
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|
